Photodynamic therapy effectively palliates gynecologic malignancies.
1Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA.
European Journal of Gynaecological Oncology
|September 12, 2013
Summary
Photodynamic therapy (PDT) using Photofrin II offers an effective treatment for recurrent gynecologic cancers. This laser-based therapy shows promise for complete response in select patients, particularly those with superficial lesions.
Area of Science:
- Oncology
- Photomedicine
Background:
- Recurrent gynecologic malignancies present a significant challenge, necessitating novel therapeutic approaches.
- Photodynamic therapy (PDT) is an emerging treatment modality utilizing photosensitizers and light activation.
Purpose of the Study:
- To evaluate the efficacy and safety of photodynamic therapy (PDT) with Photofrin II for patients with recurrent gynecologic malignancies.
- To assess response rates and toxicity in a cohort of patients with various gynecologic cancer recurrences.
Main Methods:
- Patients received intravenous Photofrin II (2 mg/kg), followed by tumor exposure to 630 nm red laser light.
- Treatment involved flexible quartz fiber delivery of laser light for uniform tumor illumination.
Main Results:
- Thirty-two patients with recurrent gynecologic malignancies underwent 45 PDT treatments.
- Complete response was observed in 82% of patients with metastatic cutaneous lesions and 24% with vaginal, cervical, or anal recurrences.
- Treatment toxicity was limited to localized burning, pain, and edema; no treatment-related deaths occurred.
Conclusions:
- Photodynamic therapy (PDT) is an effective alternative for recurrent gynecologic malignancies, especially when conventional options are limited.
- PDT offers potential for complete response and palliation in patients with superficial recurrent lesions, particularly in the absence of distant metastases.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...